Fund Holdings — Sio Capital Management, LLC

Total Portfolio Value:
$395.15M
Total Bought:
$205.84M
Total Sold:
$71.76M
Net Transaction:
+$134.08M
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Maximus, Inc.(MMS)548,086557,615+9,529$38.48M$50.95M12.89%+$12.47M
Celcuity Inc.(CELC)0786,526+786,526$0$38.85M9.83%+$38.85M
SanofiADR(SNY)187,500562,703+375,203$9.06M$26.56M6.72%+$17.50M
Dianthus Therapeutics, Inc.(DNTH)236,070577,750+341,680$4.40M$22.73M5.75%+$18.34M
Alkermes plcSHS(ALKS)0674,840+674,840$0$20.25M5.12%+$20.25M
Disc Medicine, Inc.(IRON)284,787284,7870$15.08M$18.82M4.76%+$3.74M
Merck & Co., Inc.(MRK)173,951177,300+3,349$13.77M$14.88M3.77%+$1.11M
Henry Schein, Inc.(HSIC)0219,207+219,207$0$14.55M3.68%+$14.55M
Centene Corporation(CNC)262,500387,600+125,100$14.25M$13.83M3.50%-$418.9K
Kenvue Inc.(KVUE)0844,000+844,000$0$13.70M3.47%+$13.70M
BioMarin Pharmaceutical Inc.(BMRN)225,114225,1140$12.37M$12.19M3.09%-$182.3K
GSK plcADR(GSK)0268,873+268,873$0$11.60M2.94%+$11.60M
Bright Minds Biosciences Inc.(DRUG)512,338190,764-321,574$13.38M$11.57M2.93%-$1.81M
Haemonetics Corporation(HAE)0198,035+198,035$0$9.65M2.44%+$9.65M
Aquestive Therapeutics Inc947,4891,498,095+550,606$3.14M$8.37M2.12%+$5.24M
Kalvista Pharmaceuticals Inc0683,819+683,819$0$8.33M2.11%+$8.33M
Anteris Technologies Global Corp.(AVR)1,839,0221,772,601-66,421$6.97M$7.98M2.02%+$1.01M
Crinetics Pharmaceuticals In0174,841+174,841$0$7.28M1.84%+$7.28M
Tyra Biosciences, Inc.(TYRA)810,274514,947-295,327$7.75M$7.20M1.82%-$550.2K
Rapport Therapeutics, Inc.(RAPP)0185,265+185,265$0$5.50M1.39%+$5.50M
NovoCure Limited(NVCR)0413,829+413,829$0$5.35M1.35%+$5.35M
ANI Pharmaceuticals, Inc.(ANIP)112,92355,723-57,200$7.37M$5.10M1.29%-$2.26M
Edgewise Therapeutics, Inc.(EWTX)539,730307,181-232,549$7.08M$4.98M1.26%-$2.09M
Teleflex Incorporated(TFX)040,057+40,057$0$4.90M1.24%+$4.90M
Simulations Plus Inc0320,307+320,307$0$4.83M1.22%+$4.83M
Proqr Therapeutics N VSHS EURO
SHS EURO
2,075,1392,075,1390$4.23M$4.42M1.12%+$186.8K
Shoulder Innovations, Inc.(SI)0350,000+350,000$0$4.39M1.11%+$4.39M
PMV Pharmaceuticals, Inc.(PMVP)3,735,3962,636,548-1,098,848$3.96M$3.69M0.93%-$268.4K
Septerna, Inc.(SEPN)584,435189,199-395,236$6.18M$3.56M0.90%-$2.62M
IDEAYA Biosciences, Inc.(IDYA)124,230124,2300$2.61M$3.38M0.86%+$769.0K
Aligos Therapeutics, Inc.(ALGS)335,937335,9370$2.42M$3.29M0.83%+$870.1K
Erasca, Inc.(ERAS)1,369,7481,369,7480$1.74M$2.99M0.76%+$1.25M
Vir Biotechnology, Inc.(VIR)478,343478,3430$2.41M$2.73M0.69%+$320.5K
Savara Inc.(SVRA)726,851726,8510$1.66M$2.59M0.66%+$937.6K
Ventyx Biosciences Inc1,307,964829,178-478,786$2.80M$2.58M0.65%-$220.3K
Neuroone Med Technologies Co
COM NEW
3,523,6632,360,635-1,163,028$2.39M$2.10M0.53%-$292.4K
Ovid Therapeutics Inc.(OVID)2,232,0001,427,495-804,505$736.3K$1.86M0.47%+$1.12M
BridgeBio Oncology Therapeutics, Inc.(BBOT)0130,628+130,628$0$1.51M0.38%+$1.51M
Context Therapeutics Inc.(CNTX)1,341,6361,341,6360$879.0K$1.30M0.33%+$420.7K
Senseonics Holdings, Inc.(SENS)4,852,2982,315,749-2,536,549$2.31M$1.01M0.26%-$1.30M
TELA Bio, Inc.(TELA)636,300636,3000$1.23M$948.1K0.24%-$286.3K
Avalo Therapeutics, Inc.(AVTX)72,17372,1730$360.1K$917.3K0.23%+$557.2K
Foghorn Therapeutics Inc.(FHTX)122,889122,8890$577.6K$600.9K0.15%+$23.3K
Modular Med Inc785,824785,8240$585.4K$549.9K0.14%-$35.5K
Nyxoah S ASHS
SHS
50,83950,8390$380.3K$233.9K0.06%-$146.4K
Boundless Bio, Inc.(BOLD)163,679163,6790$165.3K$201.3K0.05%+$36.0K
Aprea Therapeutics, Inc.(APRE)279,369112,223-167,146$472.1K$165.5K0.04%-$306.6K
Terns Pharmaceuticals Inc10,10010,1000$37.7K$75.9K0.02%+$38.2K
Nextcure Inc010,940+10,940$0$64.1K0.02%+$64.1K
Rocket Pharmaceuticals, Inc.W EXP 09 02 202(RCKT)400,000400,0000$13.6K$14.4K0.00%+$820
Humacyte, Inc.W EXP 08 27 202(HUMA)49,99849,9980$18.7K$12.2K0.00%-$6.5K
Alector Inc845,5310-845,531$1.18M$0—-$1.18M
Annexon, Inc.(ANNX)4,095,7640-4,095,764$9.83M$0—-$9.83M
Artivion, Inc.(AORT)158,7360-158,736$4.94M$0—-$4.94M
Astria Therapeutics Inc318,2560-318,256$1.71M$0—-$1.71M
Avanos Med Inc288,8490-288,849$3.54M$0—-$3.54M
Embecta Corp.(EMBC)31,1690-31,169$302.0K$0—-$302.0K
Enanta Pharmaceuticals, Inc.(ENTA)178,7740-178,774$1.35M$0—-$1.35M
Globus Medical, Inc.CL A(GMED)245,5700-245,570$14.49M$0—-$14.49M
MBX Biosciences, Inc.(MBX)241,0000-241,000$2.75M$0—-$2.75M
Merus N V62,7190-62,719$3.30M$0—-$3.30M
Neurocrine Biosciences, Inc.(NBIX)100,7250-100,725$12.66M$0—-$12.66M
Nextcure Inc131,3000-131,300$60.4K$0—-$60.4K
Travere Therapeutics, Inc.(TVTX)122,2100-122,210$1.81M$0—-$1.81M
Page 1 of 1
Sio Capital Management, LLC — 13F Holdings — Q3 2025 | TickerTrail